Nvidia Invests in Verily Health's AI Precision Health Platform
Verily Health, a company focused on AI for precision health, has received funding from its partner Nvidia. The investment will help Verily scale its flagship product, the Pre Platform, which turns clinical, genomic, and device data into AI-ready datasets.
The partnership between Verily and Nvidia was announced in October 2025, allowing researchers using the Pre Platform to use Nvidia's AI libraries and frameworks. This collaboration has already led to the creation of Forecast 1.0, a foundation model that integrates genomics and EHR data to improve long-term health risk prediction.
The Verily Pre Platform is being used by several institutions, including Vanderbilt, UCHealth, CU Anschutz, and RefinedScience. Despite discontinuing some projects in the past, such as its medical devices program and Value Suite, Verily's current investors include Alphabet, Series X Capital, and UCHealth.